Bened Biomedical Grants Exclusive Rights for PS128™ to M8 PharmaceuticalsDec 08, 2020Its portfolio companies address the most compelling trends in global health. The firm is currently investing out of its sixth fund. https://www.prnewswire.com/news-releases/bened-biomedical-grants-exclusive-rights-for-ps128-to-m8-pharmaceuticals-301187838.html
Dec 08, 2020Its portfolio companies address the most compelling trends in global health. The firm is currently investing out of its sixth fund. https://www.prnewswire.com/news-releases/bened-biomedical-grants-exclusive-rights-for-ps128-to-m8-pharmaceuticals-301187838.html
Comments